Tag Archive for: MindMed

Psychedelic Business Spotlight: November 19

,
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.

Psychedelic Business Spotlight: October 29

,
This week in psychedelic business news: MindMed's MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.
Why Psychedelic Stocks Have Crashed in the Last 3 Months

Why Psychedelic Stocks Have Crashed in the Last 3 Months

Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.
MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders

MindMed is currently conducting several clinical trials using psychedelic-inspired medicines, including studying LSD experiential therapy for anxiety, LSD microdosing for adult ADHD, and 18-MC for opioid withdrawal.
Psychedelic Spotlight Business Round Up July 30

Psychedelic Business Spotlight: July 30, 2021

,
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
Psychedelic Business Spotlight, July 16

Psychedelic Business Spotlight: July 16, 2021

,
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.